Clinical Study
Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis?

https://doi.org/10.1016/j.jocn.2008.10.008Get rights and content

Abstract

We reviewed and compared the clinical course and long-term prognosis of patients with non-aneurysmal subarachnoid hemorrhage (SAH) with and without a perimesencephalic pattern of hemorrhage on CT scan. In 876 patients with spontaneous SAH, 52 (5.9%) were diagnosed with non-aneurysmal SAH. Based on their CT scans, the SAH was classified as perimesencephalic non-aneurysmal SAH (PNSH) in 23 patients and non-perimesencephalic (non-PNSH) in 29 patients. The patients in the non-PNSH group were further divided into diffuse type (19 patients) and localized type (10 patients). We performed follow-up three-dimensional-CT angiography (3D-CTA) in all possible patients at least 1 year after the attack. The PNSH group had a lower rate of acute hydrocephalus (8.7%) and angiographic vasospasm (0%) complications than the non-PNSH group (37.9% and 27.6%, respectively). Only one case of rebleeding occurred in the non-PNSH group. No demonstrable source of bleeding was found on follow-up 3D-CTA, which was performed 1 year after the attack. All patients with non-aneurysmal SAH had similarly favorable long-term functional outcomes. Based on our study, patients with non-PNSH have a more complicated clinical course than those with PNSH. However, the long-term prognosis was similarly favorable for both the PNSH and non-PNSH in limited circumstances when they showed normal findings on a series of two-dimensional and 3D angiographic work-ups.

Introduction

Spontaneous subarachnoid hemorrhage (SAH) is mostly caused by rupture of a saccular aneurysm, but conventional angiography fails to reveal an aneurysm in about 15% of patients with spontaneous SAH.[1], [2], [3], [4], [5], [6], [7], [8], [9] In general, specific therapy cannot be offered to these patients and they are therefore treated with conservative therapy alone. The clinical course of spontaneous SAH varies according to location and amount of hemorrhage observed on CT scans.[10], [11] Van Gijn et al. reported a benign subgroup of patients with SAH of unknown origin, called perimesencephalic SAH.12 Perimesencephalic SAH is characterized by a CT scan pattern of hemorrhage restricted to the perimesencephalic or prepontine cisterns and accounts for 20% to 68% of all patients with angiography-negative SAH.13 However, other types of angiography-negative SAH might be susceptible to complications, such as rebleeding, vasospasm, and hydrocephalus.[14], [15] One aim of this study is to compare the clinical course of angiography-negative SAH patients with and without a perimesencephalic pattern of hemorrhage on CT scans.

Repeat angiography is usually performed about 2 weeks after ictus in most centers, and it usually yields negative results. In several published series, patients with angiography-negative SAH have a more favorable prognosis than those with a demonstrable bleeding source.[16], [17] However, these patients could potentially suffer fatal rebleeding and long-term disability, hence their long-term prognosis remains uncertain.18 Moreover, most previous studies investigating the prognosis of angiography-negative SAH were restricted to evaluating functional grades (modified Rankin scale [mRS] or Activity of Daily Living [ADL] scale).[19], [20]

We aimed to provide evidence of a benign prognosis in these patients. Therefore, all patients diagnosed with angiography-negative SAH were assessed using three-dimensional CT angiography (3D-CTA) during follow-up. The other aim of this study was to evaluate, functionally and radiologically, the prognosis of the patients with angiography-negative SAH.

Section snippets

Materials and methods

From January 2001 to June 2005, 876 patients who presented with spontaneous SAH were admitted to the Neurosurgical Department of Kyungpook National University. Each patient was diagnosed with SAH using CT scan. In 824 of these patients, diagnostic studies demonstrated saccular aneurysms or other sources responsible for the bleeding. Initial conventional angiography revealed the cause of bleeding in 815 patients. The remaining 61 patients with negative findings on the initial angiogram were

Results

The 52 patients with non-aneurysmal SAH included 28 men and 24 women who ranged in age from 27 years to 74 years (mean age, 55.4 years). CT scans showed PNSH in 23 patients (44.2%) and non-PNSH in 29 patients (55.8%). Nineteen patients with non-PNSH had a DNSH and 10 had a LNSH. The clinical grades for all patients on admission are presented with their demographic data (Table 1). Most of the 43 patients (82.7%) with non-aneurysmal SAH were classified according to the Hunt and Hess scale as

Clinical course of non-aneurysmal SAH patients

In our series, only 1 patient (1.9%) in the DNSH group experienced a second episode of SAH 2 months after the first attack, and further angiography could not reveal the source of bleeding. The incidence of rebleeding after non-aneurysmal SAH has been reported in 2.8% to 6.8% of cases and is significantly lower than that of aneurysmal SAH.[10], [15], [24], [25], [26] Due to the extremely low rate of rebleeding in our study, we could not identify a relationship between rebleeding and CT scan

Conclusion

Based on our data, patients with PNSH have an uncomplicated clinical course and those with non-PNSH have a higher rate of acute complications, especially in terms of angiographic vasospasm and acute hydrocephalus. One case of rebleeding was found in the non-PNSH group. However, the long-term prognoses were similarly favorable for both the PNSH and non-PNSH groups at least 3 years after the onset of SAH, as confirmed by 3D-CTA. This finding may be due to the advancement of angiographic

References (42)

  • G.B. Bradac et al.

    False-negative angiograms in subarachnoid haemorrhage due to intracranial aneurysms

    Neuroradiology

    (1997)
  • V. Eskesen et al.

    The prognosis in subarachnoid hemorrhage of unknown etiology

    J Neurosurg

    (1984)
  • H. Hashimoto et al.

    Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms

    J Neurosurg

    (2000)
  • R. Juul et al.

    Prognosis in subarachnoid hemorrhage of unknown etiology

    J Neurosurg

    (1986)
  • P. Canhão et al.

    Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms

    Acta Neurochir (Wien)

    (1995)
  • J. van Gijn et al.

    Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage

    Neurology

    (1985)
  • T.H. Schwartz et al.

    Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature

    Neurosurgery

    (1996)
  • J.J. Jafar et al.

    Surgery for angiographically occult cerebral aneurysms

    J Neurosurg

    (1993)
  • C. Béguelin et al.

    Subarachnoid hemorrhage with normal cerebral pan-angiography

    Neurosurgery

    (1983)
  • S. Giombini et al.

    Subarachnoid hemorrhage of unexplained cause

    Neurosurgery

    (1988)
  • D.M.C. Forster et al.

    The value of repeat pan-angiography in cases of unexplained subarachnoid hemorrhage

    J Neurosurg

    (1978)
  • Cited by (60)

    • Comparing Outcomes of Patients With Idiopathic Subarachnoid Hemorrhage by Stratifying Perimesencephalic Bleeding Patterns

      2019, Journal of Stroke and Cerebrovascular Diseases
      Citation Excerpt :

      Interestingly, these groups typically present with similar initial clinical symptoms such as sudden headache, nausea, and vomiting, and additional work-up by computed tomography (CT) must be obtained to differentiate these patients from one another.1 However, a small subset of pmSAHs closely mirrors those of aSAHs with a higher severity and incidence of complications.5-7 Because no known risk factors have been identified for patients with pmSAHs, it can be challenging to assess prognosis in the short term.

    View all citing articles on Scopus

    Present address: Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul, 135-710, Korea.

    View full text